Amoéba Completes €9.7 Million Capital Increase

Amoéba successfully completed a capital increase, raising €9.7 million through preferential subscription rights. A total of 32,294,779 new shares were issued at €0.30 per share, each paired with a warrant. Reference shareholder Nice & Green converted €6.0 million of debt, reducing Amoéba's financial burdens. This transaction also positions Amoéba to save approximately €1.5 million in financing over the next three years.

The shares and warrants will start trading on Euronext Growth Paris on October 29, 2026. This development secures Amoéba's funding needs up to September 2027, anticipating self-sufficiency through the Willa™ cosmetics platform by 2029. The transaction attracted demand up to €10.1 million, showcasing investor confidence despite market conditions.